RecruitingEarly Phase 1NCT06159504

Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania

Studying Anorectal malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Médecins du Monde
Principal Investigator
Margaret Hellard
Burnet
Intervention
sofosbuvir/velpatasvir (SOF/VEL)(drug)
Enrollment
3040 target
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (1)

Collaborators

UNITAID · Burnet Institute · University of Bristol · International Network of People who Use Drugs

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06159504 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation

← Back to all trials